FDA product code NDY: Test, Cystatin C
NDY is the FDA product code for test, cystatin c. It is a Class II device, regulated under 21 CFR 862.1225 and reviewed by the Clinical Chemistry panel. FDA has cleared 22 510(k) submissions under NDY, 1 in the last five years, from 17 different applicants. The average 510(k) review took 126 days (median 92); 259 days on average over the last three years. FDA has posted 4 recalls for NDY devices, 2 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Test, Cystatin C |
| Device class | Class II |
| Regulation | 21 CFR 862.1225 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for NDY
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 32 |
| 2018 | 1 | 31 |
| 2025 | 1 | 259 |
Compare with all 510(k) review times · Search every NDY clearance
Top NDY applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Diazyme Laboratories | 3 | 2012-03-30 |
| Dade Behring, Inc. | 3 | 2007-01-22 |
| Gentian AS | 2 | 2008-08-20 |
| SENTINEL CH. SpA | 1 | 2025-05-16 |
| Siemens Healthcare Diagnostics, Inc. | 1 | 2018-05-25 |
12 more applicants have NDY clearances. See the full list in Caduvo.
Most recent NDY clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K242585 | SENTINEL CH. SpA | Cystatin C | 2025-05-16 | 259 |
| K181082 | Siemens Healthcare Diagnostics, Inc. | ADVIA Chemistry Cystatin C_2 Assay (CYSC_2) | 2018-05-25 | 31 |
| K171072 | Siemens Healthcare Diagnostics Products GmbH | N Latex Cystatin C; N Protein Standard UY | 2017-05-12 | 32 |
| K161817 | Roche Diagnostics Operations (Rdo) | Tina-quant Cystatin C Gen.2 | 2016-07-27 | 26 |
| K141143 | Roche Diagnostics | COBAS C TINA-QUANT CYSTATIN C GEN.2 ASSAY, C.F.A.S. CYSTATIN C CALIBRATOR, CYSTATIN C GEN.2 CONTROL SET | 2014-07-17 | 76 |
Recalls for NDY devices
4 product recalls in 4 recall events; 2 initiated in the last five years and 2 still open. Most recent: 2024-06-07.
| Year | Recalls |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2024 | 2 |
Frequently asked questions
What is FDA product code NDY?
NDY is the FDA product code for test, cystatin c. It is a Class II device, regulated under 21 CFR 862.1225 and reviewed by the Clinical Chemistry panel.
What device class is NDY?
Class II, regulation 21 CFR 862.1225. Typical premarket route: 510(k).
How long does a 510(k) take for product code NDY?
Across 22 cleared submissions the average was 126 days from receipt to decision (median 92).
Which companies have the most NDY clearances?
Diazyme Laboratories (3); Dade Behring, Inc. (3); Gentian AS (2); SENTINEL CH. SpA (1); Siemens Healthcare Diagnostics, Inc. (1).
Have NDY devices been recalled?
Yes: 4 product recalls across 4 recall events; the most recent began 2024-06-07.
Next steps
- Run an FDA pathway report with predicate devices for product code NDY
- Run a recall and safety report across every NDY manufacturer
- Watch product code NDY for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times